Citation

Shoval G, Sever J, Sher L, Diller R, Apter A, Weizman A, Zalsman G. J. Child Adolesc. Psychopharmacol. 2006; 16(6): 767-775.

Affiliation

Adolescent Inpatient Unit, Geha Mental Health Center, Petah Tiqva, Israel., Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Copyright

(Copyright © 2006, Mary Ann Liebert Publishers)

DOI

10.1089/cap.2006.16.767

PMID

17201620

Abstract

Objective: The aim of this study was to investigate the link between the use of specific types of substances and suicidality in adolescent inpatients with schizophrenia and schizoaffective disorder. Methods: We performed a 10-year naturalistic retrospective study of 178 adolescent inpatients diagnosed as suffering from either schizophrenia or schizoaffective disorder. A comparison was made between the suicide-attempting adolescent inpatients and the non-attempting subjects, by the use of specific types of substances, measurements of psychotic, depressive, and aggressive symptoms, and clinical data reported during their hospitalization. Results: The suicide attempters reported considerably greater usage of inhalants and lysergic acid diethylamide (LSD). Alcohol and methylene-dioxy-methylamphethamine (MDMA) were also used significantly more by this group. However, no differences were found in the usage of cannabis, amphethamines, cocaine, and opiates. The suicide-attempting patients were found to have had more previous psychiatric admissions, a greater level of deliberate self-harm behavior, and a higher level of suicide ideation, but a decreased severity of psychotic symptoms. Conclusions: This study is the first report of the association between specific types of substances and suicidality in the high-risk population of adolescent psychotic inpatients. The strong association between inhalants, LSD, alcohol, and MDMA with suicidality is relevant to suicide prevention and intervention programs in adolescent-onset schizophrenia.

Language: en